Webinars
Explore our library of on-demand webinars to delve deeper into Datwyler’s specialization in parenteral drug packaging. Discover key subjects such as particulate control, regulatory aspects, and the pharmaceutical packaging selection process. Datwyler’s experts shed light on the innovative FirstLine® manufacturing standard, NeoFlex™ plungers tailored for vaccines and drug delivery systems, as well as the cutting-edge OmniFlex® and UltraShield™ stoppers designed to enhance patient safety.
Advancing Injectable Drug Quality: Innovations, Compliance, and Sustainability in the Healthcare Industry
When it comes to injectable drugs, quality considerations are of utmost importance to ensure patient safety and efficacy. The manufacturing process must adhere to guidelines and regulations to maintain purity, potency, and sterility and rigorous testing and quality control should detect any potential impurities or defects before market release. In this webinar, industry experts will introduce the latest quality advancements and explain how these innovations are not only making medications cleaner and safer but are also promoting sustainability in the healthcare industry.
Sealed for Safety: A Deep Dive into Container Closure Integrity
Container closure integrity (CCI) plays a vital role in the packaging of injectable drugs. It is crucial for guaranteeing the safety and effectiveness of these medications, as any compromise in the container's seal can result in microbial contamination or a decrease in drug potency. Join us for an insightful webinar where industry experts will delve into the intricacies of pharmaceutical packaging, uncovering how it is meticulously designed to prevent leakage and contamination, and ensure the utmost quality of injectable drugs.
From Discovery to Delivery: Engineering Safe and Effective Pharmaceutical Packaging
Without the appropriate packaging components, even the most effective injectable drug cannot achieve success. To engineer these components, a deep understanding of the drug's requirements and specifications, as well as the manufacturing and filling environments, is crucial. Additionally, considering the needs of the end-users is vital. In this webinar, industry experts will delve into the engineering requirements and considerations necessary to design, manufacture, and supply packaging components that safeguard drug integrity, prevent contamination, and above all, prioritize patient safety.
Flawless Functionality: Optimizing Injectable Drug Stability and Performance
When analyzing the functionality of injectable drugs, it is crucial to consider various factors, including the pharmaceutical packaging. It is essential to evaluate the desired field usage of the drug to ensure its safety and compatibility with the packaging. Additionally, optimizing patient comfort and compliance should be a priority, taking into account factors like the required injection volume, needle gauge, puncture frequency, and injection site. It is imperative to carefully assess and understand the functionality of the full packaging system together, and not just its individual pieces. Join us in this webinar as industry experts delve into the vital components of injectable drugs and share their valuable insights on creating a best-in-class drug packaging solution.
What's New and What to Do: Critical Updates to Regulatory Requirements for Injectable Packaging
In the fast-paced world of pharmaceuticals, it is crucial for injectable drug developers to stay informed about the ever-changing requirements set forth by regulatory authorities. These updates not only ensure enhanced patient safety, but also help maintain strict adherence to standards when prescribing or administering injectable medications. In this webinar, industry experts will educate the audience about the latest updates to USP and EU GMP requirements, and will explain how to confidently navigate the complexities of injectable drug regulations.
Out With the Old: Advancing the Chemical Cleanliness of Rubber Components
Rubber components play a vital role in the primary packaging of pharmaceuticals, offering excellent sealing capabilities. However, there has been growing concern about the presence of undesirable impurities like nitrosamines in rubber materials. This webinar sheds light on the significant advances made in the chemical cleanliness of rubber components over the past decades. Industry experts provide insights into the extractables that can be expected from both older and more modern rubber formulations and will demonstrate how selecting the right compound and utilizing readily available extractables data can streamline the E&L testing process.
Particulate Matters: Categorizations, Considerations, and Compendia
Particulate matter, as defined by the USP, refers to the presence of mobile undissolved particles in solutions, excluding gas bubbles. It is a critical aspect to consider for those involved in packaging injectable drug products, requiring a thorough understanding, mitigation, and adherence to regulatory standards. During this exclusive webinar, experts will delve into the fundamental aspects of categorizing, considering, and complying with particulate matter.
Different coated rubber solutions for safe storage of innovative drugs
As requirements continue to increase with respect to advancements for next-generation drug products, drug developers must be aware of the critical considerations needed to safely store these innovative injectables. At Pharmapack Paris 2024, Camille Ermine provides insight in the latest pharmaceutical packaging solutions to meet these ever-changing challenges of the pharmaceutical and biotech markets.
A Quality-by-Design Approach to Annex 1 and Parenteral Packaging Manufacturing and Supply
Pharmaceutical regulations are evolving and with that evolution there is a need for parental packaging manufacturers to meet the increasing demands. This webinar will provide insight on the latest trends and challenges in the pharmaceutical industry and how these challenges can be addressed by having a Quality by Design (QbD) approach for the manufacturing of parenteral packaging components. The elastomeric manufacturing process will be introduced and the audience will gain an understanding of how packaging suppliers are using a QbD approach to meet Annex 1 expectations.
Post-COVID Supply Chains: Lockdown Lessons Learned
During the COVID-19 pandemic, supply chains around the world were disrupted, especially those in the pharmaceutical industry with the critical task of delivering life-saving vaccines worldwide. Three years after the start of the pandemic, the industry has learned valuable lessons for how to de-risk the supply chain and prepare for future emergency scenarios. In this webcast, the audience will learn how COVID-19 impacted the pharmaceutical industry and the impact it had on drug supply, how to mitigate risk in the future, and how to create a future-proof supply chain that will leave the industry prepared for what comes next.
Ultra-low Extractable Formulations and Beyond: Different Coating Technologies and their Unique Benefits
Rubber components are often an essential part of the primary packaging system of parenteral drugs. This webcast aims to highlight the considerable evolution that was made with regards to chemical cleanliness of rubber components and their impact on extractables and leachables. Furthermore it addresses the two main coating technology standards, spray and film coating, and their common characteristics as well as their unique features and benefits.
Advantages and Challenges of Sterilization Techniques for Parenteral Packaging
With regulations becoming ever-stricter and patient safety at top of mind, industry leaders in parenteral packaging are continuously looking for the most suitable way to sterilize components to ensure product quality, reduce cost of ownership, and improve patient safety. In this webcast, experts will inform the audience about the leading sterilization practices for parenteral packaging, explore scenarios to determine preferred sterilization techniques, and discuss the overall benefits to the pharmaceutical industry and, ultimately, the patient.
Understanding Break-loose and Glide Force Behavior in Prefilled Syringe Systems
Prefilled syringes (PFS) are effective drug-delivery systems that are patient-friendly and conserve drug product. Though these systems offer clear advantages as a drug delivery platform, their designation as combination products offer additional regulatory challenges. As a combination product, the mechanical functionality of the syringe-elastomer system is an important consideration. An element to consider is the break-loose force (BLF) and gliding force (GF) profile. In this webcast, the importance of a patient-appropriate BLF & GF profile and the importance of optimization for efficacious drug-delivery is discussed, in addition to factors that affect BLF & GF profiles, force exertion considerations, and strategies for optimal elastomer selection.
Building a Better Prefilled Syringe for Vaccines
Over the years, the trend towards drug delivery devices has steadily increased, leading towards a higher demand for cartridges. Cartridges are commonly used in most drug delivery devices on the market, such as pen injectors and on-body injectors. As new devices and delivery methods become available, it is important that device and drug developers have a wide selection of parenteral packaging for these cartridge applications. In this webinar, industry experts discuss the benefits and challenges of transferring vaccines from vial applications to prefilled syringes, the components critical to the success of the vaccine products, and how to prepare your packaging toolbox for time-critical vaccine development and distribution.
The Role of Parenteral Drug Packaging in Patient Safety
When it comes to drug delivery, patient safety is of the utmost importance. In order to ensure life-saving drug products are delivered both safely and effectively, drug developers and their packaging suppliers must ensure that specific product requirements are met and patient and healthcare provider use are taken into account. In this webinar, common challenges for packaging a safe and effective drug product will be discussed, as well as how packaging suppliers can help mitigate these risks. Case studies and examples will be introduced to explore real-world scenarios and implications for patients and their providers. The audience will leave this webinar with an understanding of the importance of patient-centric delivery and how to prepare for the future challenges that may arise.
The Digital Transformation: Preparing the Pharma Supply Chain for the Digitalization of Healthcare
Accelerated by the COVID-19 pandemic, the healthcare industry is quickly transforming to address the needs of the digital era. Healthcare professionals, drug developers, and patients are all critical adaptors of these new technologies and processes, which means that the pharmaceutical value chain must also prepare to meet this new challenge. In this webinar, industry experts will discuss the digital trends currently happening in healthcare and the innovative solutions being developed by the pharmaceutical supply chain, specifically in regards to parenteral packaging. Focusing on data gathering, data science, simulation, automation and on-demand care, these experts will provide a detailed look at how these technological advancements will support drug developers to achieve a smooth transition to digitalized healthcare and how they will, ultimately, create a safer and more efficient healthcare experience for patients.
Drug Delivery Devices for Net Zero Emissions: A Pharma Supply Chain Collaboration
As a sector, the pharmaceutical industry’s carbon emissions are even greater than that of the automotive industry - in the region of 55% more emission intensive. Drug delivery devices and the primary and secondary packaging account for a proportion of the CO2 emissions of combination products based on their design. The urgency of action required for global GHG emissions reduction means that parenteral packaging suppliers cannot work in isolation if they are to reach these GHG reduction goals. The Alliance to Zero was established to directly address this issue, by adopting the principles of the circular economy to facilitate the transition of the pharma sector to net zero emissions by 2030. This webcast will introduce the ambition of the Alliance of Zero, explain the methodology and impact the association intends to have and how pharma suppliers can participate.
Sterilization Techniques for Parenteral Packaging
Choosing the right sterilization technique for your drug product and its packaging is not always a simple decision. While most packaged drug products have specific requirements, newer sterilization techniques offer innovative ways of ensuring sterility that may be more suitable than standard sterilization processes. In this webcast, the audience will learn about standard sterilization processes, be introduced to newer techniques, and understand how these techniques have been applied to parenteral packaging components.
Parenteral Packaging for Cartridges in Drug Delivery Devices
Over the years, the trend towards drug delivery devices has steadily increased, leading towards a higher demand for cartridges. Cartridges are commonly used in most drug delivery devices on the market, such as pen injectors and on-body injectors. As new devices and delivery methods become available, it is important that device and drug developers have a wide selection of parenteral packaging for these cartridge applications. This webcast will introduce the audience to packaging components for cartridges used in drug delivery devices today and explore future trends that are emerging in the market.
.png "Pandemic Thumbnail 2021 (1)")
Pandemic Preparedness: Ensuring a Robust Parenteral Packaging Supply Chain
For drug developers, being ready to develop and mass produce drugs for a pandemic situation is an essential part of their risk management strategy. But what about the packaging suppliers that create containers, stoppers, plungers, and seals to protect and deliver these vital drugs? This webinar will discuss work that has been done to develop, manufacture, and distribute parenteral packaging components for the on-going COVID-19 pandemic, while also touching on the critical aspects to consider to prepare for a future pandemic or natural disaster scenario.
Using Quality Principles to Analyze and Quantify Particulate Matter in Parenteral Packaging
Parenteral drug developers are faced with multiple challenges when it comes to packaging their drug products. One of the most critical challenges is protecting the drug product from particulate matter. Particulates pose a risk to the overall quality and effectiveness of the drug, causing contaminated products to be discarded during manufacturing, or, in a worst case scenario, during a recall event. In order to prevent these costly scenarios, it is imperative that measures are put into place to analyze, quantify, and mitigate particulate matter in drug product packaging. In this webinar, the audience learns which measures are put into place to analyze, quantify, and mitigate particulate matter in drug product packaging.
Best Practices for Meeting and Exceeding Regulatory Standards in Primary Packaging
In today’s regulatory environment, stricter requirements are being placed on primary packaging components for parenteral drug products. Packaging suppliers are making efforts to meet these requirements in order to ensure their products are accepted by both regulatory bodies and pharmaceutical companies. This webcast will analyze United States Pharmacopeia (USP) General Chapters <381> and <382> and discuss ways to not only meet the regulatory requirements currently in place, but to exceed them with an effort to create a future-proof regulatory pathway.
.png "Zero Defects Thumbnail 2020 (1)")
Striving for Zero Defects: Use of QbD Principles to Mitigate Contamination
This webinar focuses on innovations in the manufacturing of parenteral packaging components to address the demanding needs for packaging sensitive drugs, such as biologics.